Furthermore, no MLH1 gene promoter hypermethylation was found in any of the MSI-H rectal or sigmoid carcinomas of the combined series, whereas it was found in 53% of carcinomas located elsewhere (P = 0.004). This evidence concerns the gene MLH1 and carcinoma.